Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.925
-0.005 (-0.53%)
At close: Apr 28, 2026, 4:00 PM EDT
0.925
0.00 (0.00%)
Pre-market: Apr 29, 2026, 8:47 AM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $8.52 million as of April 29, 2026. Its market cap has increased by 33.06% in one year.
Market Cap
8.52M
Enterprise Value
685.10K
1-Year Change
33.06%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $8.52M, a decrease of -24.64%. That is a compound annual growth rate of -3.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 8.40M | 110.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 10.37M |
| Aprea Therapeutics | 10.32M |
| Evogene | 9.92M |
| Bolt Biotherapeutics | 9.83M |
| GT Biopharma | 9.59M |
| CalciMedica | 9.29M |
| Liminatus Pharma | 9.27M |
| NuCana | 8.78M |